Novel Coronavirus (SARS-CoV-2/COVID-19)
The AHA released the latest edition of the COVID-19 Snapshot, which highlights the critical needs of hospitals and health systems during the deepening public health emergency.
Department of Health and Human Services Secretary Alex Azar, Jan. 8 at 1 p.m. ET will discuss public health initiatives that HHS has worked on over the past four years, as well as activities related to the COVID-19 pandemic, including vaccination efforts.
The AHA urged the Department of Health and Human Services to take certain steps to speed COVID-19 vaccinations.
The past 10 months have been filled with jarring and dissonant images, scenes that have prompted us to say, “never thought we’d see that in our country.” Unfortunately, we now have to add yesterday’s storming of the U.S. Capitol and assault on our democracy to that mix.
The Federal Bureau of Investigation and the Cybersecurity and Infrastructure Security Agency have observed—since the summer of 2020—a surge of DoppelPaymer ransomware attacks against emergency services and healthcare entities. This activity has negatively impacted the provision of critical services…
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
The Centers for Disease Control and Prevention reported 21 cases of anaphylaxis, a life-threatening allergic reaction, among the nearly 1.9 million people who received a first dose of the Pfizer COVID-19 vaccine between Dec. 14 and 23.
In this podcast, Priya Bathija, Vice President of Strategic Initiatives at the AHA, moderates a discussion between Tom Nordwick, CEO of Uvalde Memorial Hospital, and Phil Sklar, Co-founder and CEO of the National Bobblehead Hall of Fame and Museum, on continued PPE needs of hospitals and how non-…
The Food and Drug Administration warned that Curative’s SARS-Cov-2 test could produce false results and that health care providers should strictly follow its authorization and labeling.
The Food and Drug Administration reminded the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.